FINNENCE▪
00:00:00 UTCSYS ONLINE
FINNENCE ▪ THE WIRE FILE

THE WIRE · № 69482

News▲ Bullish

Draper and Partners Awarded ARPA-H Funding to End Cold-Chain Dependence for Cell Therapies and Cancer Drugs

EXHIBIT · mmx.prnewswire.com
KINDNews
DIRECTION▲ Bullish
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-07 16:15 UTC
LAST UPDATE2026-10-07 16:15 UTC
STATEactive

01 THE MACHINE READ

WHY IT MATTERS.

ARPA-H funding for cold-chain-free cell therapies could reduce logistics costs and expand biotech distribution.

Federal grant advances cell therapy distribution
CATALYST TO WATCH

Phase 1 milestones and follow-on funding

MAIN RISK

Early-stage program may not scale

FULL DISPATCH

CAMBRIDGE, Mass., Oct. 7, 2026 /PRNewswire/ -- Draper received up to $7.3 million other transaction award (OTA) from the Advanced Research Projects Agency for Health (ARPA-H) for Phase 1 of the agency's BioStabilization Systems (BoSS) program, which aims to develop new methods to produce,...

02 THE STORY SO FAR

THE RECORD, IN ORDER.

STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.

03 WHO'S INVOLVED

ENTITIES ON FILE.

AFFECTEDHealthcare

04 RECEIPTS

THE SOURCE RECORD.

1 SOURCES CONFIRMED
№ 01prnewswireprnewswire.com · PRIMARY2026-10-07 16:15 UTCOPEN RECEIPT →

05 PROPAGATION

WHAT THIS TOUCHES.

KEEP READING THE MACHINE

OPEN THE MACHINE →THE PREDICTION LEDGER →

Summaries are generated and may contain errors — every claim links its sources.